Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 24Completed 9Not yet recruiting 3Terminated 2Recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Non-small Cell Lung Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER × icotinib × Clear all
NCT06517953 2024-07-25

IcomBine

Sun Yat-sen University

Phase 2 Recruiting
23 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT05104788 2021-11-03

NeoIpower

Peking University Cancer Hospital & Institute

Phase 2 Recruiting
27 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡